Aquestive Therapeutics, Inc. vs Deva Holding A.S.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Aquestive Therapeutics, Inc. and Deva Holding A.S. are worth about the same: $508 M and $526 M (market caps of Oct 30, 2026 for Aquestive Therapeutics, Inc. and Jan 5, 2024 for Deva Holding A.S.). Deva Holding A.S.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Aquestive Therapeutics, Inc. AQST · #12,470 in the world | Deva Holding A.S. DEVA.IS |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇹🇷 Turkey |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | Pharmaceutical |
| Founded | 2004 | — |
| Size | ||
| Market cap | $508 M | $526 M* |
| Revenue | $45 M | — |
| Net income | $-84 M | — |
| Employees | 147 | — |
| Valuation | ||
| Price to sales | 10.4× | — |
| Free cash flow yield | -10.4% | — |
| Profitability | ||
| Gross margin | 58.3% | — |
| Operating margin | -159.5% | — |
| Net margin | -188.1% | — |
| Growth | ||
| Revenue growth | -22.6% | — |
| Revenue growth, 3 years a year | -2.3% | — |
| Cash | ||
| Free cash flow margin | -119.0% | — |
| Strength scores | ||
| Piotroski F-score | 2 of 9 | — |
| Altman Z-score zone | distress | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Jan 2024 |
Questions and answers#
Which is bigger, Aquestive Therapeutics, Inc. or Deva Holding A.S.?
Aquestive Therapeutics, Inc. and Deva Holding A.S. are worth about the same: $508 M and $526 M (market caps of Oct 30, 2026 for Aquestive Therapeutics, Inc. and Jan 5, 2024 for Deva Holding A.S.). Deva Holding A.S.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.